Ultrasound-Guided Erector Spinae Plan Block for Colorectal Surgery

Not Applicable

• Conditions: Colorectal Cancer; Postoperative Pain
• Interventions: Drug: Bupivacaine Hcl 0.25% infiltration; Drug: Bupivacaine Hcl 0.25% ESP block

• Registration Number: NCT04313764
• Lead Sponsor: Ataturk University

Brief Summary

Colorectal cancer is a common and lethal disease. It still remains the third most common cause of cancer death in women and the second leading cause of death in men. Pain control is an important direction of postoperative management in malignancy surgery. Inadequate pain control increases cardiac and respiratory complications in these critical patients. Erector spinae plane (ESP) block is a recently described regional anesthesia technique that blocks the dorsal and ventral rami of the spinal nerves and the sympathetic nerve fibers. While the ESP block has been shown to provide effective postoperative analgesia after thoracic, and abdominal surgeries.

Our aim in this study was to investigate bilateral thoracic ESP block for providing successful postoperative pain management following colorectal surgery.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-03-17
• Study First Submitted QC: 2020-03-17
• Study First Posted: 2020-03-18
• Status Verified: 2020-06
• Last Update Submitted: 2020-06-03
• Last Update Posted: 2020-06-04
• Study Start: 2020-06-18
• Primary Completion: 2020-07-30
• Study Completion: 2020-08-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• American Society of Anesthesiologist's physiologic state I-II-III patients undergoing Colorectal surgery

Exclusion Criteria

• renal or hepatic insufficiency, chronic pain, patients with an allergic reaction to anesthesia and analgesia drugs to be used

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group Infiltration	Bupivacaine Hcl 0.25% infiltration	Wound infiltration with 20 ml %0.25 bupivacaine
Group ESPB	Bupivacaine Hcl 0.25% ESP block	Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side

Primary Outcome Measures

Name	Time	Method
Opioid Consumption	Postoperative first 24 hours	Opioid consumption postroperative period

Secondary Outcome Measures

Name	Time	Method
Visual Analog Pain Score	Postoperative first 24 hours	Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)

Trial Locations

Locations (1)

Ataturk University; 🇹🇷 Erzurum, Turkey